Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation in vivo CRISPR gene editing ...

Zebrafish (Danio Rerio) have emerged as a powerful bioengineering platform for next-generation drug discovery, offering an unparalleled combination of ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...

Financial giants have made a conspicuous bearish move on CRISPR Therapeutics. Our analysis of options history for CRISPR Therapeutics (NASDAQ:CRSP) revealed 9 unusual trades. Delving into the details, ...

Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...

Last August, KJ Muldoon was born with a potentially fatal genetic disorder. Just six months later, he received a Crispr treatment designed just for him. Muldoon has a rare disorder known as CPS1 ...

The "Biopharmaceuticals - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Biopharmaceuticals market is estimated at $412.1 billion in 2024 and is ...

Description: Jianwen Que, MD, PhD, Faculty Director of Genetically Modified Mouse Models Shared Resource (GMMMSR) will share an overview of GMMMSR. GMMMSR provides essential services for cancer ...